GRAL

At a glance

GRAIL, Inc. (GRAL) is listed on NASDAQ and classified in Diagnostics & Research, part of the Healthcare sector. It is headquartered in Menlo Park, United States and has 910 employees. The company is worth $5.68B. Revenue was $147.17M in fiscal 2025, up 17.2% from the year before. It reported a net loss of $408.35M. The share price is 23.7% below its 52-week high of $166.48. 3 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Cliff Asness (AQR Capital Management), at $14.16M. In that quarter, 3 of them reduced the position. Over the last 30 days, company insiders sold $7.35M of its stock on the open market and bought none. $2.74M of those sales were scheduled in advance under 10b5-1 plans.

Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.

Key metrics

Market cap

$5.68B

P/E

—

Forward P/E

—

P/B

2.2x

Dividend yield

0.00%

Payout

—

EPS

-$9.29

ROE

-16.12%

Profit margin

-236.95%

Revenue growth

+25.70%

Beta

2.84

52-week high

$166.48

52-week low

$41.50

History

Year by year, from the annual reports; dividends from the payments themselves.

Investors holding this

Major managers that reported this stock in their latest 13F.

• CA
  Cliff Asness− Reduced

  AQR Capital Management · Q2 2026
  $14.16M

  211.34K shares · 0.0% of portfolio
• TS
  Two Sigma− Reduced

  Two Sigma Investments · Q2 2026
  $1.87M

  27.43K shares · 0.0% of portfolio
• RT
  Renaissance Technologies− Reduced

  Renaissance Technologies · Q2 2026
  $628.08K

  9.2K shares · 0.0% of portfolio

Indicators, year by year

The last 2 closed years, each at that year’s closing price and reported numbers.

Median of the years shown; P/E years above 200x are left out.

Others in the same sector

Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.

About the company